Factors Affecting BAT Activation in PET/CT
Factors Affecting Brown Adipose Tissue (BAT) Activation in Cancer Patients Undergoing 18F-FDG-PET/CT
1 other identifier
observational
80
0 countries
N/A
Brief Summary
The aim of the present study is to evaluate the factors affecting BAT activation in 18F-FDG-PET/CT in different tumours
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2022
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 9, 2022
CompletedFirst Posted
Study publicly available on registry
October 13, 2022
CompletedStudy Start
First participant enrolled
November 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2025
CompletedOctober 13, 2022
September 1, 2022
2.8 years
October 9, 2022
October 9, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
the main factors that affect appearance of BAT in PET/CT studies and try to avoid these factors.
the amount and SUV max of the detected BAT activation in PET scan correlated with the patient prognosis.
from 7/2019 to 7/2022
Interventions
18F-fluorodeoxyglucose positron emission tomography/computed tomography (18FFDG PET/CT) is a non-invasive imaging modality used for staging and surveillance of various types of malignancies through imaging of glucose metabolism in cancer cells.
Eligibility Criteria
cancer patients undergoing PET/CT
You may qualify if:
- This study will include all patients presented with different types of tumors.
- patients conscious to provide informed consent
You may not qualify if:
- Patients who have contraindications to PET/CT scanning such as: a blood glucose level higher than 150-200 mg/dL, uncontrolled diabetics.
- Intolerance of PET/CT due to claustrophobia will be excluded from the study.
- Patients under age of 18
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- resident doctor
Study Record Dates
First Submitted
October 9, 2022
First Posted
October 13, 2022
Study Start
November 1, 2022
Primary Completion
August 1, 2025
Study Completion
October 1, 2025
Last Updated
October 13, 2022
Record last verified: 2022-09